Genetic Engineering — Current Affairs 2026

Current Affairs Connections

Recent developments and news linked to Genetic Engineering.

CRISPR-based Gene Therapies Show Promising Results for Sickle Cell Disease and Beta-Thalassemia in Clinical Trials

Late 2023 - Early 2024

Recent clinical trials have demonstrated significant success for CRISPR-Cas9 based gene therapies in treating severe genetic blood disorders like sickle cell disease and beta-thalassemia. Patients treated with these therapies have shown sustained improvements, with some achieving functional cures, reducing or eliminating the need for regular blood transfusions or pain management. This marks a pivotal moment for gene editing, moving from experimental stages to potential therapeutic realities, showcasing the immense potential of genetic engineering to address previously incurable diseases. The regulatory approvals for such therapies in Western countries are setting precedents for global adoption and ethical considerations.

UPSC Angle: This highlights the medical applications of genetic engineering, specifically gene therapy and CRISPR technology. UPSC questions could focus on the ethical implications of gene editing, the regulatory challenges for such advanced therapies in India, or the socio-economic impact of making these treatments accessible and affordable, linking to Article 21 (Right to Health).

India's Regulatory Framework for Gene-Edited Crops (SDN-1/2) Streamlined to Boost Agricultural Innovation

March 2022 (Notification) & Ongoing Implementation

In a significant policy shift, the Ministry of Environment, Forest and Climate Change (MoEFCC) in India notified that certain gene-edited organisms, specifically those without foreign DNA (SDN-1 and SDN-2 categories), would be exempted from the stringent biosafety regulations applicable to conventional Genetically Modified Organisms (GMOs). This move aims to accelerate research and development in gene-edited crops, potentially allowing for faster market access for varieties with enhanced traits like drought resistance or improved nutrition, without the lengthy approval process of the Genetic Engineering Appraisal Committee (GEAC) for traditional GMOs. This reflects a global trend towards differentiated regulation based on the nature of the genetic modification.

UPSC Angle: This is a direct policy update relevant to agriculture and science & technology. UPSC could ask about the rationale behind differentiating gene-edited crops from GMOs, the potential impact on food security and farmer income, or the challenges in implementing such a nuanced regulatory framework, linking to environmental protection (Article 48A) and scientific temper (Article 51A).

Advancements in mRNA Technology, Spurred by COVID-19 Vaccines, Pave Way for New Cancer Therapies and Infectious Disease Prevention

2024-2025 (Ongoing Research & Trials)

The unprecedented success and rapid development of mRNA-based COVID-19 vaccines showcased the power of genetic engineering in vaccine technology. This has spurred massive investment and research into applying mRNA platforms for other diseases. Currently, numerous clinical trials are underway for mRNA-based cancer vaccines, designed to train the immune system to recognize and destroy cancer cells, and for vaccines against other infectious diseases like influenza, HIV, and Zika. This expansion demonstrates how genetic engineering principles, particularly in designing and delivering specific genetic instructions, are revolutionizing preventive and therapeutic medicine beyond the initial pandemic response.

UPSC Angle: This connects genetic engineering directly to public health, disease prevention, and the future of medicine. Questions could explore the mechanism of mRNA vaccines, their advantages over traditional vaccines, the role of biotechnology in global health security, and the ethical considerations around rapid vaccine development and distribution.